Global clinical diagnostics market will reach $ 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.
Highlighted with 82 tables and 94 figures, this 170-page report “Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Region.
Based on Test, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Assay Kits & Reagents
• Software & Services
By Indication the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications
By Patient Gender the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Male Patients
• Female Patients
By Age Group the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Age 44 and below
• Age 45-64
• Age 65 and over
By End User the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Test, Product, and Indication, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Global Market by Test 43
3.1 Market Overview by Test 43
3.2 Lipid Panel 45
3.3 Infectious Disease Testing 46
3.4 Liver Panel 47
3.5 Complete Blood Count (CBC) 48
3.6 Electrolyte Testing 49
3.7 Renal Panel 50
3.8 Other Tests 51
4 Segmentation of Global Market by Product 52
4.1 Market Overview by Product 52
4.2 Instruments 54
4.3 Assay Kits & Reagents 55
4.4 Software & Services 56
5 Segmentation of Global Market by Indication 57
5.1 Market Overview by Indication 57
5.2 Cardiovascular 59
5.3 Cancer 60
5.4 Infectious Disease 61
5.5 Stroke 62
5.6 Chronic Lower Respiratory Diseases 63
5.7 Diabetes 64
5.8 Other Indications 65
6 Segmentation of Global Market by Patient Gender 66
6.1 Market Overview by Patient Gender 66
6.2 Male Patients 68
6.3 Female Patients 69
7 Segmentation of Global Market by Age Group 70
7.1 Market Overview by Age Group 70
7.2 Age 44 and below 72
7.3 Age 45-64 73
7.4 Age 65 and over 74
8 Segmentation of Global Market by End User 75
8.1 Market Overview by End User 75
8.2 Hospital & Clinics Laboratory 77
8.3 Diagnostic Laboratory 78
8.4 Point-of-Care Testing 79
8.5 Other End Users 80
9 Segmentation of Global Market by Region 81
9.1 Geographic Market Overview 2021-2031 81
9.2 North America Market 2021-2031 by Country 85
9.2.1 Overview of North America Market 85
9.2.2 U.S. 89
9.2.3 Canada 93
9.2.4 Mexico 95
9.3 European Market 2021-2031 by Country 97
9.3.1 Overview of European Market 97
9.3.2 Germany 101
9.3.3 U.K. 103
9.3.4 France 105
9.3.5 Spain 107
9.3.6 Italy 109
9.3.7 Russia 111
9.3.8 Rest of European Market 113
9.4 Asia-Pacific Market 2021-2031 by Country 115
9.4.1 Overview of Asia-Pacific Market 115
9.4.2 Japan 119
9.4.3 China 122
9.4.4 Australia 124
9.4.5 India 126
9.4.6 South Korea 128
9.4.7 Rest of APAC Region 130
9.5 South America Market 2021-2031 by Country 132
9.5.1 Argentina 135
9.5.2 Brazil 137
9.5.3 Chile 139
9.5.4 Rest of South America Market 141
9.6 MEA Market 2021-2031 by Country 142
9.6.1 UAE 145
9.6.2 Saudi Arabia 147
9.6.3 South Africa 149
9.6.4 Other National Markets 151
10 Competitive Landscape 152
10.1 Overview of Key Vendors 152
10.2 New Product Launch, Partnership, Investment, and M&A 155
10.3 Company Profiles 156
Abbott Laboratories 156
Becton, Dickinson and Company 158
BioMerieux SA 159
Bio-Rad Laboratories Inc. 160
Bio-Reference Laboratories 161
Bioscientia Healthcare 162
Charles River Laboratories 163
Danaher Corporation 164
Hoffmann-La Roche AG 165
Hologic Inc. 166
Qiagen NV 167
Siemens Healthcare 168
Thermo Fisher Scientific 169
RELATED REPORTS 170
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Ěý
Ěý
*If Applicable.
